Health Condition 1: F900- Attention-deficit hyperactivity disorder, predominantly inattentive type Health Condition 2: F901- Attention-deficit hyperactivity disorder, predominantly hyperactive type Health Condition 3: F902- Attention-deficit hyperactivity disorder, combined type Health Condition 4: F908- Attention-deficit hyperactivity disorder, other type Health Condition 5: F909- Attention-deficit hyperactivity disorder, unspecified type
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of ADHD as per DSM-5 IQ greater than or equal to 80 Availability of at least one parent as an informant Ability to comprehend instructions and cooperate for intervention Ability to read and understand English and/or Hindi
Exclusion criteria
Exclusion criteria: Metal implants or skin lesions near electrode site History of epilepsy, seizures, or other known organic neurological disorders Patients with autism, psychosis or bipolar disorder Uncooperative patient/ parent Has not been a part of any interventional trial in previous 3 months Drug-naive or drug-free for at least 48 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Working Memory, Response Inhibition and AttentionTimepoint: Pre and Post Assessment (after 5 sessions) | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the spectral values and Oxygenated and Deoxygenated Haemoglobin Concentrations in the dlPFC. Timepoint: Pre and Post Assessment (after 5 sessions) | — |
Countries
India
Contacts
All India Institute of Medical Sciences (AlIMS), New Delhi